JAMA Oncology

JAMA Oncology

JAMA Oncology is a monthly medical journal that is peer-reviewed and released by the American Medical Association, concentrating on cancer research. This journal addresses a wide range of topics related to medical oncology, radiation oncology, and surgical oncology, along with various subspecialties. You can find a complete list of the subjects it covers on the JAMA Oncology website.

International, Trade/B2B
English
Journal

Outlet metrics

Domain Authority
91
Ranking

Global

#15103

United States

#5352

Health/Medicine

#56

Traffic sources
Monthly visitors

Articles

  • 6 days ago | jamanetwork.com | Samantha House

    The Childhood Opportunity Index (COI), a multidimensional measure of neighborhood conditions associated with health outcomes, is increasingly used in research and public health.1 COI has increased over time among children in the US2; however, COI trends for hospital-based encounters have not been explored.

  • 1 week ago | jamanetwork.com | David Kim

    A Call to End Daylight Saving Time—Implications for Public Health In most of the United States and Canada, daylight saving time (DST) begins on the second Sunday in March and ends on the first Sunday in November at 2 am.

  • 1 week ago | jamanetwork.com | Heather Prendergast

    Key PointsQuestion  Does an Education and mHealth Empowerment (E2) intervention delivered by a multidisciplinary team to patients identified in the emergency department (ED) with high systolic blood pressure (SBP) lead to greater reductions in SBP at 6 months?

  • 1 week ago | jamanetwork.com | Shruti Gupta

    Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury Podcast (12:23) 0:00 / 0:00 Key PointsQuestion  Is prophylactic receipt of intravenous (IV) magnesium associated with a lower incidence of cisplatin-associated acute kidney injury (CP-AKI)?

  • 1 week ago | jamanetwork.com | Rebecca Voelker

    Atrial fibrillation is an abnormal heart rhythm that can cause stroke, heart failure, heart attack, chronic kidney disease, dementia, and death. Atrial fibrillation is classified as paroxysmal (intermittent episodes lasting 7 days or less), persistent (lasting more than 7 days), long-standing persistent (lasting more than 1 year), or permanent.1 In the US, atrial fibrillation affects about 10.55 million people and is more common among men than women.